Clinical Trial Update: Omega-3 Fatty Acids in Bariatric Gastric Bypass Surgery: Effect on Liver Volume, Immune Response and Erythrocyte Function [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating omega-3 fatty acids in bariatric gastric bypass to assess liver volume, immune response, and erythrocyte function in morbid obes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Morbid Obesity

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Medical Center Alkmaar | Conditions: Morbid Obesity | Phase 4 | Status: COMPLETED